RandalK.WadaMD

Pediatric Hematology & Oncology • Honolulu, HI

Physician

Join to view full profile

Dr. Wada is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wada's full profile

Already have an account?

Office
1319 Punahou St
Pediatric Ambulatory Unit
Honolulu, HI 96826
Phone+1 808-983-8551

Fax+1 808-983-8005

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 1986 - 1989
Children's Hospital Los AngelesResidency, Pediatrics, 1985 - 1986
Childrens Hospital Los AngelesInternship, Transitional Year, 1983 - 1984
Emory University School of MedicineClass of 1983

Certifications & Licensure

HI State Medical License 1996 - 2026
CA State Medical License 1985 - 2020
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma Start of enrollment: 2008 Jan 14
Completed
Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Roles: Contact, Principal Investigator
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission Start of enrollment: 2012 Jun 01
Active, not recruiting
Phase 2
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer Start of enrollment: 2013 Mar 04
Completed
Not Applicable
Molecular-Guided Therapy for Childhood Cancer Start of enrollment: 2014 Jul 08
Completed
Not Applicable
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy Start of enrollment: 2015 Sep 01
Recruiting
Phase 2
Trial of Tolcapone With Oxaliplatin for Neuroblastoma Start of enrollment: 2015 Dec 01
Terminated
Phase 1
Neuroblastoma Maintenance Therapy Trial Start of enrollment: 2016 Feb 01
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

3 citations
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
Giselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, Jacqueline Kraveka, William Ferguson
Genome Medicine. 2024-02-12
7 citations
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Javier Oesterheld, William Ferguson, Jacqueline M Kraveka, Genevieve Bergendahl, Thomas Clinch
Journal of Clinical Oncology. 2024-01-01
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
Don Eslin, Peter E Zage, Genevieve Bergendahl, Elizabeth Lewis, William Roberts
International Journal of Cancer. 2023-09-01

Grant Support

Regulation Of The N-MYC Oncogene In NeuroblastomaNational Institute Of Neurological Disorders And Stroke1996–2004
Regulation Of The N MYC Oncogene In NeuroblastomaNational Institute Of Neurological Disorders And Stroke1997–1998
Regulation Of The N-MYC Oncogene In NeuroblastomaNational Institute Of Neurological Disorders And Stroke1995–1996
N-MYC Oncogene Regulation In Human NeuroblastomaNational Institute Of Neurological Disorders And Stroke1993–1995